Comparison of Metronidazole q12h to q8h in Combination With Other Antibiotics on the Clinical Outcome and Readmission Rate of Patients With Appendicitis and Diverticulitis

Authors:

Abstract
Background. Pharmacokinetic, pharmacodynamic and limited published clinical data support the administration of metronidazole in a twice daily (q12h) regimen versus three times daily (q8h). As part of an Antimicrobial Stewardship initiative, we started promoting this change in practice in March 2015 during weekly rounds with the General Surgery team. The objectives of this study are to determine if metronidazole 500 mg q12h differs from q8h in patients with appendicitis or diverticulitis, regarding 30-day clinical outcomes and readmission rates.